Max Planck Institute for Biological Intelligence researchers have identified over 60 transcriptomic neuron types in the ...
Researchers have created a novel imaging-technology combination that can capture gene activity in individual bacteria in ...
Request To Download Free Sample of This Strategic Report @ Highlighted with 39 tables and 46 figures, this 120-page report Asia Pacific Transcriptomics Market 2021-2031 by Component (Instruments, ...
Request To Download Free Sample of This Strategic Report @ Highlighted with 42 tables and 37 figures, this 121-page report Europe Transcriptomics Market 2021-2031 by Component (Instruments, ...
The FDA has approved a companion diagnostic to determine if patients with HR-positive, HER2-ultralow metastatic breast cancer ...
13d
Allied Market Research published a report, titled, "Cytogenetics Market by Product (Consumable, Instrument, Software and Service), by Technique (Comparative Genome Hybridization, Fluorescence in Situ ...
The PATHWAY HER2 (4B5) test, the first and only FDA approved companion diagnostic for assessing HER2-low status since 2022, is now also approved to aid in the assessment of HER2-ultralow status for ...
gained approval in 2022 for unresectable or metastatic HER2-low breast cancer -- defined by an FDA-approved test as IHC 1+ or IHC 2+/in situ hybridization (ISH)‑. This approval included patients ...
Nanoyang Group, Tianjin Key Laboratory of Advanced Carbon and Electrochemical Energy Storage, School of Chemical Engineering and Technology, National Industry-Education Integration Platform of Energy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback